GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

3 Jan 2012 07:00

RNS Number : 8394U
ViaLogy PLC
03 January 2012
 



ViaLogy PLC ("ViaLogy" or "the Company")

 

Business update

 

Pasadena, January 3, 2012. ViaLogy PLC (VIY LSE/AIM), a provider of reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas Exploration and Production companies based on proprietary, patented active signal processing technology, reports substantial progress has been achieved in consolidating relationships with major oil and gas exploration companies on three continents during the last quarter of 2011. In Asia, a contract with a National Oil Company awaits government approval to transfer seismic information before it is signed. In the US, a pilot contract with a supermajor has been completed and acknowledged as positive by the client, and for a large independent exploration company a blind test determined porosity features across a 60 sq km prospect in Texas. In Europe, at the invitation of another supermajor, ViaLogy scientists briefed over 50 company geophysicists around the world on QuantumRD, its powerful computational weak signal processing technology which aids the discovery, characterization, and sizing of hydrocarbon deposits.

In updating the Company's progress to bring the technology to the attention of the O&G giants, CEO Robert W. Dean acknowledges that there have been time frustrations beyond ViaLogy's control; "Unforeseen delays unrelated to our work have affected the consummation of contracts," he said.

In Asia, ViaLogy expects contract awards from two global E&P companies. The first such contract, with a National Oil Company, the contract award process has been dictated by standard procedures and timelines already in place for work performed on government leased fields. Now, however, negotiations have been concluded and contract terms agreed. The final phase involves obtaining approval from the government for the export of seismic data to ViaLogy's US headquarters in Pasadena. In the second case, many similar rules apply both to leaseholder and ViaLogy, but the ViaLogy board believe that the contract process is now on track to award.

In the US, results from ViaLogy's pilot contract for its current supermajor client have been acknowledged as positive and have presented results and conclusions on porosity values that would be unattainable with technology now in use by the client. Their quantitative analysis continues, and should result in further contract work under our already-signed Master Services Agreement.

Another ViaLogy success, this one for a large US-based independent, determined porosity features across a 60 sq km prospect in Texas. In this blind test of the technology porosity values were determined in five Permian formations using seismic data from which other analysis techniques had been unable to extract this information. The client confirms this and is conducting further quantitative evaluation. Accurate predictions of porosity are fundamental in identifying hydrocarbon locations, and a measure of QuantumRD's ability to add breakthrough value in the seismic analysis industry.

Involvement in Europe resulted from an unsolicited approach to ViaLogy by a second supermajor in September. Now detailed technical examination is underway and has been ongoing for over three months. The process has extended to multiple locations, and the supermajor has engaged its most senior technical and scientific staff, as well as its operational management.

"Running this gauntlet of rigorous technical scrutiny takes time and concentration, but is at the heart of client recruitment for us in this 'big tent' part of the industry. It will serve ViaLogy well going forward, and should result in contracted project work," said Mr. Dean.

 

 

For further information:

 

ViaLogy PLC

Terry Bond, Chairman - UK & Europe +44 (0) 1235 834 734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 207 107 8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery.

ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABLGDBIBGBGDD
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.